Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/13/2003WO2003093320A2 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses
11/13/2003WO2003093318A1 Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis
11/13/2003WO2003093316A2 Immunoglobulin-domain containing cell surface recognition molecules
11/13/2003WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003WO2003093307A2 Mycobacterial antigens and uses thereof
11/13/2003WO2003093296A2 Kinase anchor protein muteins, peptides thereof, and related methods
11/13/2003WO2003093295A2 Secretion signal vectors
11/13/2003WO2003093291A2 Antisense oligonucleotides for identifying drug targets and enhancing cancer therapies
11/13/2003WO2003092869A1 Method for chemical analysis of biological materials
11/13/2003WO2003092740A1 Non-viral gene delivery system
11/13/2003WO2003092739A1 Non-viral gene delivery system
11/13/2003WO2003092738A1 Drug- or gene-carrier composition having lowered hemagglutinin activity
11/13/2003WO2003092737A1 Fusions of cytokines and tumor targeting proteins
11/13/2003WO2003092716A2 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders
11/13/2003WO2003092715A2 Proteins involved in the regulation of energy homeostasis
11/13/2003WO2003092714A2 Peptide variants of ige constrained by beta-lactam bond
11/13/2003WO2003092687A1 Methods of modulating smooth muscle contractility
11/13/2003WO2003092630A2 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
11/13/2003WO2003092627A2 High throughput screening assay for detecting a dna sequence
11/13/2003WO2003092612A2 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003092600A2 Site specific listeria integration vectors and methods for using the same
11/13/2003WO2003092598A2 Treatment for pompe disease
11/13/2003WO2003092594A2 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
11/13/2003WO2003092592A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003WO2003092582A2 Chimeric ebola virus envelopes and uses therefor
11/13/2003WO2003092579A2 Compositions and methods for treating cancer with an oncolytic viral agent
11/13/2003WO2003092370A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
11/13/2003WO2003092363A2 Transgenic high tryptophan plants
11/13/2003WO2003092362A2 Seed specific usp promoters for expressing genes in plants
11/13/2003WO2003092361A2 Temporal seed promoters for expressing genes in plants
11/13/2003WO2003092360A2 Novel glyphosate-n-acetyltransferase (gat) genes
11/13/2003WO2003080654A3 Helicobacter flagellar, motility polypeptides
11/13/2003WO2003072739A3 Trans-splicing mediated imaging of gene expression
11/13/2003WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof
11/13/2003WO2003068955A3 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/13/2003WO2003068804A3 Novel insect cell line
11/13/2003WO2003064689A3 Methods for identifying polyadenylation sites and genes thereof
11/13/2003WO2003064447A3 Immune-modulating peptide
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003061363A3 Mutations caused by activation-induced cytidine deaminase
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003052140A3 High throughput analysis and detection of multiple target sequences
11/13/2003WO2003052067A3 Vector mediated organelle transfection
11/13/2003WO2003043565A3 Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
11/13/2003WO2003042244A3 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
11/13/2003WO2003040689A3 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
11/13/2003WO2003040391A3 Method for producing and identifying soluble protein domains
11/13/2003WO2003040372A3 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
11/13/2003WO2003035671A3 Methods for detecting genetic haplotypes by interaction with probes
11/13/2003WO2003034985A3 Telomerase interference
11/13/2003WO2003033673A3 High-throughput transcriptome and functional validation analysis
11/13/2003WO2003033654A3 Direct targeting binding proteins
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003032713A3 COFFEE PLANT WITH REDUCED α-D-GALACTOSIDASE ACTIVITY
11/13/2003WO2003031942A8 Reagents and methods useful for detecting diseases of the breast
11/13/2003WO2003031621A3 A human g protein coupled receptor
11/13/2003WO2003031459A3 Modulation of the expression of genes dependent on stat-1
11/13/2003WO2003030944A3 Inhibition of stat-1
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003029430A3 Tandem repeat markers
11/13/2003WO2003029404A3 MAST CELL RasGRP4 COMPOSITIONS AND RELATED METHODS
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2003027258A3 RECOMBINANT DNA PROCESSES USING A dNTP MIXTURE CONTAINING MODIFIED NUCLEOTIDES
11/13/2003WO2003024502A3 Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream
11/13/2003WO2003023058A3 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids
11/13/2003WO2003018830A3 METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE
11/13/2003WO2003018826A3 Method for producing vitamin b12
11/13/2003WO2003018813A3 Ashbya gossypii enzymes
11/13/2003WO2003018750A3 Molecular interaction sites of 23s ribosomal rna and methods of use
11/13/2003WO2003018134A3 Bioadhesive compositions and methods for enhanced mucosal drug absorption
11/13/2003WO2003017917A3 Use of microbiology non-viral substances for treating acne
11/13/2003WO2003014346A3 High-throughput dna-isolation and transfection for analysing the function of genes or genetic products
11/13/2003WO2003012119A3 Nucleic acid amplification method
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003012096A3 Plant stress regulated genes
11/13/2003WO2003011019A3 Lethal mouse model for testing of pharmaceuticals and vaccines against neospororis
11/13/2003WO2003010183A3 Process for preparing variant polynucleotides
11/13/2003WO2003008607A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
11/13/2003WO2003008600A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
11/13/2003WO2003008534A3 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
11/13/2003WO2003007886A3 Plant ion channels and methods
11/13/2003WO2003006657A3 Gene-regulatory elements for gene therapy, for the prevention and diagnosis of metastases and for the gene therapy of tumours
11/13/2003WO2003004605A3 Mesenchymal cells and osteoblasts from human embryonic stem cell
11/13/2003WO2003000889A3 Identification of ses-1 and the uses of the same
11/13/2003WO2002102984A3 Hdac9 polypeptides and polynucleotides and uses thereof
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002098443A3 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
11/13/2003WO2002097056A3 Method for generating replication defective viral vectors that are helper free
11/13/2003WO2002095058A9 Emission ratiometric indicators of phosphorylation
11/13/2003WO2002095002A3 N4 virion single-stranded dna dependent rna polymerase
11/13/2003WO2002094867A3 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/13/2003WO2002094250A3 Therapeutic uses of lna-modified oligonucleotides in infectious diseases
11/13/2003WO2002092831A3 Method for identifying ligands for g protein coupled receptors
11/13/2003WO2002090549A3 Compositions and methods for the modulation of viral maturation
11/13/2003WO2002086448A3 Detection of microsatellite instability and its use in diagnosis of tumors
11/13/2003WO2002083920A3 Nucleic acid sequences useful in the detection and treatment of various cancers
11/13/2003WO2002083889A3 Methods for the production of minicircles
11/13/2003WO2002081440A3 Methods for the production of products in host cells
1 ... 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 ... 4023